Drug intelligence / Profile preview

Premi-TAT

Development stage
Unknown
Lead developer
Premium Serums and Vaccines
Modality
Antibody-Based Therapeutics
Administration
Intramuscular, Subcutaneous
01

Overview

Premi-TAT is an equine-derived polyclonal antitoxin developed by Premium Serums and Vaccines for the treatment and prophylaxis of tetanus. It consists of enzyme-refined equine antibodies (immunoglobulins) that specifically target and neutralize tetanospasmin, the neurotoxin produced by *Clostridium tetani*. By binding to the circulating toxin, Premi-TAT prevents it from attaching to nerve endings and causing the characteristic muscle spasms associated with the disease. The product is available in both liquid and lyophilized (freeze-dried) formulations, typically at a strength of 1500 International Units (IU), and is manufactured according to British Pharmacopoeia (B.P.) standards.

Brand names
Premi-TATPremi-TAT 1500Premi-TAT1500Premi-TAT-1500
Other names
Tetanus Antitoxin 1500 IUEquine Tetanus AntitoxinTetanus Antitoxin (Equine)Tetanus Antitoxin 1500 IU (liquid & lyophilized)

Beyond the preview

Go deeper on Premi-TAT.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Premi-TAT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call